The Enterprise Value as of December 2025 (TTM) for Captor Therapeutics Spolka Akcyjna (CTX.WA) is 365.50M

According to Captor Therapeutics Spolka Akcyjna’s latest financial reports and current stock price. The company's current Enterprise Value is 365.50M. This represents a change of 66.17% compared to the average of 219.96M of the last 4 quarters.

Captor Therapeutics Spolka Akcyjna (CTX.WA) Historical Enterprise Value (quarterly & annually)

How has CTX.WA Enterprise Value performed in the past?

The mean historical Enterprise Value of Captor Therapeutics Spolka Akcyjna over the last ten years is 475.91M. The current 365.50M Enterprise Value has changed 7.58% with respect to the historical average. Over the past ten years (40 quarters), CTX.WA's Enterprise Value was at its highest in in the June 2021 quarter at 691.94M. The Enterprise Value was at its lowest in in the June 2020 quarter at -5279000.00.

Captor Therapeutics Spolka Akcyjna (CTX.WA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Captor Therapeutics Spolka Akcyjna Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Captor Therapeutics Spolka Akcyjna (CTX.WA) Average Enterprise Value

How has CTX.WA Enterprise Value performed in the past?

The current Enterprise Value of Captor Therapeutics Spolka Akcyjna (CTX.WA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Captor Therapeutics Spolka Akcyjna (CTX.WA) Enterprise Value vs. Peers

How is CTX.WA’s Enterprise Value compared to its peers?

Captor Therapeutics Spolka Akcyjna’s Enterprise Value is greater than Synthaverse S.A. (348.28M), greater than Molecure S.A. (116.44M), greater than Poltreg S.A. (88.22M), greater than Mabion S.A. (109.33M), less than Bioton S.a. (387.75M), greater than Pure Biologics Spólka Akcyjna (47.48M), greater than Medicalgorithmics S.A. (348.27M), greater than NanoGroup S.A. (89.30M), greater than Urteste S.A. (49.76M), less than Ryvu Therapeutics S.A. (676.03M),

Build a custom stock screener for Captor Therapeutics Spolka Akcyjna (CTX.WA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Captor Therapeutics Spolka Akcyjna using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Captor Therapeutics Spolka Akcyjna (CTX.WA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Captor Therapeutics Spolka Akcyjna or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.